The diagnostic and therapeutic management of leptomeningeal carcinomatosis
- 1 October 2004
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 15 (suppl_4), iv285-iv291
- https://doi.org/10.1093/annonc/mdh941
Abstract
The diagnostic and therapeutic management of leptomeningeal carcinomatosis, Annals of Oncology, Volume 15, Issue suppl_4, 1 October 2004, Pages iv285–iv291, httThis publication has 73 references indexed in Scilit:
- Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis—a case reportLung Cancer, 2003
- Leptomeningeal Carcinomatosis and Intramedullary Spinal Cord Metastases from Lung CancerClinical Nuclear Medicine, 2001
- Comparative spine imaging in leptomeningeal metastasesJournal of Neuro-Oncology, 1995
- Hormonal ablation as effective therapy for carcinomatous meningitis from prostatic carcinomaCancer, 1994
- Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastases and leptomeningeal carcinomatosis in patients with breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- HMFG1 antigen: A new marker for carcinomatous meningitisInternational Journal of Cancer, 1989
- MR of cranial and spinal meningeal carcinomatosis: comparison with CT and myelographyAmerican Journal of Roentgenology, 1988
- Leptomeningeal cancer in leukemia and solid tumorsCurrent Problems in Cancer, 1988
- Elevation of Carcinoembryonic Antigen in Cerebrospinal Fluid Among Patients With Meningeal CarcinomatosisMayo Clinic Proceedings, 1986
- Carcinomatous Meningitis in Small Cell Lung CancerThe American Journal of the Medical Sciences, 1984